Cognitive impairment in Parkinson’s disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health

作者: Jennifer G. Goldman , Beth A. Vernaleo , Richard Camicioli , Nabila Dahodwala , Roseanne D. Dobkin

DOI: 10.1038/S41531-018-0055-3

关键词:

摘要: People with Parkinson's disease (PD) and their care partners frequently report cognitive decline as one of greatest concerns. Mild impairment affects approximately 20-50% people PD, longitudinal studies reveal dementia in up to 80% PD. Through the Disease Foundation Community Choice Research Award Program, PD community identified maintaining function major unmet needs. In response, a working group experts across multiple disciplines was organized evaluate needs, current challenges, future opportunities related Specific conference goals included defining state field gaps regarding issues from patient, partner, healthcare professional viewpoints; discussing non-pharmacological interventions help maintain function; forming recommendations for what can do at all stages health; proposing ideas how professionals approach changes This paper summarizes discussions conference, first by addressing is currently known about dysfunction several that are often suggested Second, based on discussions, we provide considerations health when experiencing impairment. Furthermore, highlight key knowledge need be addressed order advance research cognition improve clinical care.

参考文章(118)
J. López-Barneo, P. Mir, L. Gao, F. J. Díaz-Corrales, F. Carrillo, J. Díaz-Martín, M. T. Caceres-Redondo, M. Carballo, A. Palomino, Brain‐derived neurotrophic factor G196A polymorphism and clinical features in Parkinson’s disease Acta Neurologica Scandinavica. ,vol. 122, pp. 41- 45 ,(2010) , 10.1111/J.1600-0404.2009.01253.X
Connie Marras, Alexander I. Tröster, Jaime Kulisevsky, Glenn T. Stebbins, The tools of the trade: a state of the art "How to Assess Cognition" in the patient with Parkinson's disease. Movement Disorders. ,vol. 29, pp. 584- 596 ,(2014) , 10.1002/MDS.25874
Jamie Eberling, Lona Vincent, Jennifer G. Goldman, Daniel Weintraub, Jaime Kulisevsky, Connie Marras, Glenn Stebbins, Karl Kieburtz, Therapeutic development paths for cognitive impairment in Parkinson's disease: Report of a regulatory roundtable Journal of Parkinson's disease. ,vol. 4, pp. 585- 589 ,(2014) , 10.3233/JPD-140385
Fabian J. David, Julie A. Robichaud, Sue E. Leurgans, Cynthia Poon, Wendy M. Kohrt, Jennifer G. Goldman, Cynthia L. Comella, David E. Vaillancourt, Daniel M. Corcos, Exercise improves cognition in Parkinson's disease: The PRET‐PD randomized, clinical trial Movement Disorders. ,vol. 30, pp. 1657- 1663 ,(2015) , 10.1002/MDS.26291
Amie L. Peterson, Charles Murchison, Cyrus Zabetian, James B. Leverenz, G. Stennis Watson, Thomas Montine, Natasha Carney, Gene L. Bowman, Karen Edwards, Joseph F. Quinn, Memory, mood, and vitamin D in persons with Parkinson's disease Journal of Parkinson's disease. ,vol. 3, pp. 547- 555 ,(2013) , 10.3233/JPD-130206
Jennifer G. Goldman, Daniel Weintraub, Advances in the treatment of cognitive impairment in Parkinson's disease Movement Disorders. ,vol. 30, pp. 1471- 1489 ,(2015) , 10.1002/MDS.26352
Glenda M. Halliday, James B. Leverenz, Jay S. Schneider, Charles H. Adler, The neurobiological basis of cognitive impairment in Parkinson's disease. Movement Disorders. ,vol. 29, pp. 634- 650 ,(2014) , 10.1002/MDS.25857
Jennifer G. Goldman, Caroline Williams-Gray, Roger A. Barker, John E. Duda, James E. Galvin, The spectrum of cognitive impairment in Lewy body diseases Movement Disorders. ,vol. 29, pp. 608- 621 ,(2014) , 10.1002/MDS.25866